1,916 material Form 8-K filings that 1,609 companies we cover made with the SEC in July 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
EQT said in a preliminary Form 8-K that it expects a total gain on derivatives of $45 million for the three months ended June 30, 2026, and net cash settlements received on derivatives of $73 million. The figures are preliminary and will be finalized in the company's Form 10-Q or earnings release, so the filing shows hedging results rather than full quarterly results.
Expected total gain on derivatives of $45 million for the three months ended June 30, 2026
Net cash settlements received on derivatives of $73 million, including $76 million received on NYMEX natural gas hedges and $3 million paid on basis and liquids hedges
No premiums paid or received for derivatives that settled during the period
Final amounts will be reported in the Form 10-Q for the period ended June 30, 2026 or in the corresponding earnings release
Kestra Medical reported fiscal fourth-quarter 2026 revenue of $28.6 million, up 66%, and gave fiscal 2027 revenue guidance of $137 million, 44% above fiscal 2026. On July 10, 2026, it also entered a five-year senior secured term loan facility of up to $200.0 million, with $75.0 million funded at closing and used to repay its prior loan, which matters to shareholders because it adds debt secured by substantially all company assets.
Fiscal 4Q26 revenue was $28.6 million, up 66%, and gross margin was 54.8% versus 44.3% a year earlier.
FY27 revenue guidance is $137 million, compared with FY26 revenue of $95.1 million.
GAAP net loss was $38.8 million for the quarter versus $51.1 million a year earlier, but $131.6 million for the full year versus $113.8 million in FY25.
The July 10, 2026 loan has a $200.0 million facility, matures July 10, 2031, and requires at least $20.0 million in minimum liquidity.
JPMorgan Chase reported second-quarter 2026 net income of $21.2B and diluted EPS of $7.70, up from $6.2B and $2.46 a year earlier, with managed revenue of $58.0B up 27% year over year. The results include a $4.6B net gain tied to Visa shares and $1.0B of equity investment gains; excluding these significant items, net income was $16.9B and EPS was $6.14. The Firm also raised its full-year 2026 adjusted expense outlook to about $107.5B, citing higher volume- and revenue-related expenses.
Net income $21.2B and EPS $7.70 for 2Q26; excluding significant items, net income $16.9B and EPS $6.14
Managed revenue $58.0B, up 27% YoY; expense $27.3B, up 15% YoY
Significant items: $4.6B net gain related to Visa shares and $1.0B of equity investment gains
FY2026 adjusted expense outlook of about $107.5B, increased from prior outlook; FY2026 net interest income outlook about $105.5B
Citigroup reported second-quarter 2026 net income of $5.8 billion, or $3.15 per diluted share, up from $4.0 billion, or $1.96 per share, a year earlier, on revenues of $24.8 billion, up 14%. The company said it will raise its planned dividend by 12% and has launched a $30 billion buyback plan, which the filing presents as a way to return more capital to shareholders.
Q2 2026 revenues of $24.8 billion, up 14% from $21.7 billion in Q2 2025
Diluted EPS of $3.15 versus $1.96 in the prior-year quarter, helped by a lower share count from repurchases
Planned dividend to increase 12% and a $30 billion buyback plan launched
Common Equity Tier 1 capital ratio of 12.8%, up from 12.7% at the end of the prior quarter
Fastenal reported second-quarter 2026 results with net sales up 14.7% to $2.39 billion and net income up 15.9% to $383 million, or $0.33 per diluted share. Operating margin held at 21.0%, and operating cash flow fell 4.6% to $266 million as receivables grew, which the company attributed to strong sales growth late in the quarter.
Net sales were $2.39 billion, up 14.7% from $2.08 billion in the second quarter of 2025, with daily sales up 14.7%.
Net income was $383 million, up 15.9%, and diluted EPS was $0.33 versus $0.29 a year earlier.
Operating cash flow was $266 million, down 4.6%, or 69.4% of net income versus 84.4% a year earlier.
Shareholders received $305.1 million in dividends and share repurchases, or 79.7% of net income.
Goldman Sachs reported second-quarter 2026 net revenues of $20.34 billion and net earnings of $6.63 billion, compared with $14.58 billion in revenue for the same quarter of 2025. Diluted EPS was $20.98, up from $10.91 a year earlier, and the board raised the quarterly dividend to $5.00 per share from $4.50 starting in the third quarter, which matters to shareholders because it increases cash returned to them.
Net revenues were $20.34 billion, up 39% from the second quarter of 2025 and 18% from the first quarter of 2026.
Diluted EPS was $20.98 versus $10.91 a year earlier; net earnings were $6.63 billion.
Quarterly dividend increased to $5.00 per share from $4.50, payable September 29, 2026 to holders of record on September 1, 2026.
Operating expenses rose 26% year over year to $11.67 billion; the firm returned $5.36 billion to common shareholders during the quarter.
Bank of America reported second quarter 2026 net income of $9.1 billion, or $1.21 per diluted share, up from $7.2 billion, or $0.90 per share, a year earlier. Revenue rose 15% to $31.6 billion, and the company returned $8.0 billion to shareholders through dividends and share repurchases during the quarter.
Net income of $9.1 billion versus $7.2 billion in 2Q25, up 27%
Diluted EPS of $1.21 versus $0.90 a year earlier, up 34%
Revenue of $31.6 billion, up 15%; noninterest expense of $18.6 billion, up 8%
Returned $8.0 billion to shareholders: $2.0 billion in dividends and $6.0 billion in common stock repurchases
JPMorgan Chase reported second-quarter 2026 net income of $21.2 billion, or $7.70 per diluted share, up from $15.0 billion, or $5.24 per share, a year earlier. The results include a $4.6 billion net gain on Visa shares and $1.0 billion of gains on certain equity investments; excluding these significant items, net income was $16.9 billion, or $6.14 per share, which the filing says is up 13%.
Reported net revenue was $57.3 billion, up 28% from $44.9 billion in the second quarter of 2025; managed revenue was $58.0 billion, up 27%.
Noninterest expense rose 15% to $27.3 billion, and the provision for credit losses was $2.5 billion.
The Firm paid a common dividend of $1.50 per share ($4.0 billion) and made $6.2 billion of net common stock repurchases in the quarter.
Book value per share was $133.01 at June 30, 2026, up 9% from a year earlier; the filing does not include updated guidance.
Wells Fargo reported second quarter 2026 net income of $6.4 billion, or $2.00 per diluted share, up from $1.60 a year earlier, on total revenue of $22.6 billion, up 9%. The company also said it repurchased $3.0 billion of common stock in the quarter and expects its third quarter 2026 dividend to rise to $0.50 per share from $0.45, subject to board approval.
Diluted EPS of $2.00 vs. $1.60 in the second quarter of 2025, up 25%
Total revenue of $22,622 million, up 9% from a year earlier; noninterest expense up 2% to $13,661 million
Repurchased 37.4 million shares, or $3.0 billion, of common stock in the second quarter
Third quarter 2026 dividend expected at $0.50 per share, up from $0.45; CET1 ratio was 10.3% at June 30, 2026
SemiLEDs reported preliminary results for the fiscal third quarter ended May 31, 2026, with revenue of $9.1 million, up from $1.1 million in the prior quarter, and GAAP net income of $1.5 million, or $0.18 per diluted share, compared with a net loss of $603 thousand in the prior quarter. The company said the revenue increase reflected higher buy-sell equipment purchase orders and that it anticipates more such orders in the fourth quarter of fiscal 2026. The filing also lists an Item 4.01 auditor change, but the text provided does not describe it.
Q3 fiscal 2026 revenue was $9.1 million, compared with $1.1 million in Q2 fiscal 2026.
GAAP net income attributable to stockholders was $1.5 million, or $0.18 per diluted share, versus a net loss of $603 thousand, or $(0.07) per share, in Q2.
GAAP gross margin rose to 27% from 1%; cash and cash equivalents were $6.0 million at May 31, 2026, versus $4.0 million at February 28, 2026.
The 8-K includes Item 4.01 (Auditor Change), but the filing text provided does not give details of the change.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.